Plasticell announces grant of fundamental CombiCult patents in USA and Japan
“Plasticell's proprietary technology breaks the major bottleneck in current stem cell research. Having followed CombiCult™'s development for almost a decade, I am delighted that the importance of this revolutionary technology is now being recognised through multiple industry awards and patents”, commented Sir Martin Evans FRS, a founding member of Plasticell’s Scientific Advisory Board and recipient of the Nobel prize for the isolation of embryonic stem cells.
Dennis Saw, CEO of Plasticell added, “Since 2002, Plasticell has continually innovated and expanded intellectual property coverage to secure its leading position in the stem cell space. Granted patents in the USA, Europe and Japan mean that the CombiCult™ process, which underlies many of our technologies, is now protected in all the major biotech markets which we operate in.”
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.